Microbial influences in inflammatory bowel diseases.

PubWeight™: 9.20‹?› | Rank: Top 0.1%

🔗 View Article (PMID 18242222)

Published in Gastroenterology on February 01, 2008

Authors

R Balfour Sartor1

Author Affiliations

1: Department of Medicine, Center for Gastrointestinal Biology and Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. rbs@med.unc.edu

Associated clinical trials:

The Effect of Riboflavin in Crohn's Disease (RISE-UP) | NCT02538354

FMT in Pediatric Crohn's Disease (FMTPCD) | NCT03194529

Articles citing this

(truncated to the top 100)

Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29

The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol (2009) 13.87

Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe (2008) 11.08

Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun (2009) 7.48

Intestinal mucosal barrier function in health and disease. Nat Rev Immunol (2009) 7.15

Inflammatory bowel disease. Annu Rev Immunol (2010) 7.10

Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature (2011) 6.43

Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol (2009) 6.10

Microbes in gastrointestinal health and disease. Gastroenterology (2008) 4.65

Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe (2008) 4.14

The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol (2012) 3.88

Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A (2009) 3.58

Evaluation of 16S rDNA-based community profiling for human microbiome research. PLoS One (2012) 3.49

Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe (2011) 3.46

Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS One (2008) 3.36

Experimental and analytical tools for studying the human microbiome. Nat Rev Genet (2011) 3.30

High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol (2011) 3.11

Toward defining the autoimmune microbiome for type 1 diabetes. ISME J (2010) 3.03

Efficient and robust RNA-seq process for cultured bacteria and complex community transcriptomes. Genome Biol (2012) 3.02

Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol (2012) 2.97

NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest (2013) 2.96

Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr Gastroenterol Rep (2010) 2.93

The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology (2014) 2.73

Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes (2010) 2.70

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis (2010) 2.62

Human disease-drug network based on genomic expression profiles. PLoS One (2009) 2.62

Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science (2014) 2.59

Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis (2009) 2.44

From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42

Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology (2008) 2.42

The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol (2014) 2.32

Crohn's disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol (2009) 2.23

Crohn disease--associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae. J Clin Invest (2011) 2.10

TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology (2008) 2.06

Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics (2012) 2.04

Metagenomics and personalized medicine. Cell (2011) 2.00

Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology (2009) 1.96

The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol (2011) 1.86

Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition. PLoS One (2012) 1.82

Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut (2015) 1.80

Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis (2010) 1.79

The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog (2010) 1.77

Interplay of host microbiota, genetic perturbations, and inflammation promotes local development of intestinal neoplasms in mice. J Exp Med (2014) 1.76

Proof of concept of microbiome-metabolome analysis and delayed gluten exposure on celiac disease autoimmunity in genetically at-risk infants. PLoS One (2012) 1.74

The human microbiome and its potential importance to pediatrics. Pediatrics (2012) 1.74

NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res (2010) 1.72

Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med (2009) 1.71

Microbiota, disease, and back to health: a metastable journey. Sci Transl Med (2012) 1.70

The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. Ann Surg (2010) 1.69

Influence of fecal sample storage on bacterial community diversity. Open Microbiol J (2009) 1.68

Crohn's disease is associated with restless legs syndrome. Inflamm Bowel Dis (2010) 1.66

Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One (2012) 1.66

Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol (2011) 1.65

Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr (2011) 1.63

An update on the use and investigation of probiotics in health and disease. Gut (2013) 1.62

Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol (2012) 1.61

Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection. Infect Immun (2009) 1.59

Vitamin D receptor negatively regulates bacterial-stimulated NF-kappaB activity in intestine. Am J Pathol (2010) 1.57

Modulation of immune homeostasis by commensal bacteria. Curr Opin Microbiol (2011) 1.57

The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis. Curr Opin Gastroenterol (2009) 1.57

Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut (2015) 1.55

Intestinal fibrosis in IBD--a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol (2009) 1.51

Fusobacterium detected in colonic biopsy and clinicopathological features of ulcerative colitis in Japan. Dig Dis Sci (2014) 1.51

Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol (2010) 1.50

Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum. Proc Natl Acad Sci U S A (2010) 1.50

Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol (2010) 1.50

The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol (2009) 1.50

Investigating the biological and clinical significance of human dysbioses. Trends Microbiol (2011) 1.48

Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med (2009) 1.45

Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. J Leukoc Biol (2009) 1.45

Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis (2010) 1.44

An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer. J Exp Med (2010) 1.42

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol (2010) 1.41

Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology (2015) 1.40

A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol (2013) 1.40

Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol (2011) 1.38

Alterations to chromatin in intestinal macrophages link IL-10 deficiency to inappropriate inflammatory responses. Eur J Immunol (2016) 1.38

Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J (2013) 1.35

Methods for generating and colonizing gnotobiotic zebrafish. Nat Protoc (2008) 1.35

Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol (2013) 1.34

Patterns and scales in gastrointestinal microbial ecology. Gastroenterology (2009) 1.33

Colonic gene expression profile in NHE3-deficient mice: evidence for spontaneous distal colitis. Am J Physiol Gastrointest Liver Physiol (2008) 1.32

New pathophysiological insights and modern treatment of IBD. J Gastroenterol (2010) 1.31

Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn's disease. J Gastroenterol (2012) 1.31

Think small: zebrafish as a model system of human pathology. J Biomed Biotechnol (2012) 1.30

Infection mobilizes hematopoietic stem cells through cooperative NOD-like receptor and Toll-like receptor signaling. Cell Host Microbe (2014) 1.30

Gene-environment interactions in chronic inflammatory disease. Nat Immunol (2011) 1.30

Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon. Proc Natl Acad Sci U S A (2010) 1.29

Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease. PLoS One (2012) 1.28

Prevalence of Campylobacter species in adult Crohn's disease and the preferential colonization sites of Campylobacter species in the human intestine. PLoS One (2011) 1.27

Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut (2011) 1.26

Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy (2011) 1.26

TLR2 mediates gap junctional intercellular communication through connexin-43 in intestinal epithelial barrier injury. J Biol Chem (2009) 1.25

Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection. PLoS One (2013) 1.24

Immunopathogenesis of inflammatory bowel disease. Self Nonself (2011) 1.24

High-throughput quantitative analysis of the human intestinal microbiota with a phylogenetic microarray. Appl Environ Microbiol (2009) 1.24

Inhibitory CD8+ T cells in autoimmune disease. Hum Immunol (2008) 1.23

Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis. J Gastroenterol (2011) 1.23

The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA. Immunol Rev (2012) 1.23

Small intestinal nematode infection of mice is associated with increased enterobacterial loads alongside the intestinal tract. PLoS One (2013) 1.23